AstraZeneca’s Nexium, Prilosec Get Clean Bill Of Health From FDA
Agency says there is no evidence of either proton-pump inhibitor leading to cardiovascular risk.
Agency says there is no evidence of either proton-pump inhibitor leading to cardiovascular risk.